Showing 8961-8970 of 20387 results for "".
- Study: Test Improves the Risk Stratification of Patients with Stage I Melanomahttps://reachmd.com/news/study-finds-decisiondx-melanoma-significantly-improves-the-risk-stratification-of-patients-with-stage-i-melanoma-compared-to-american-joint-committee-on-cancer-8th-edition-staging/2462252/Results from a recent study showed the potential of a 31-gene expression profile (31-GEP) test in improving the prognosis for patients diagnosed with stage I cutaneous melanoma. Despite being considered at low risk for metastasis or melanoma-specific death, patients with stage I cutaneous
- Retatrutide Lowers A1C and Weight in Phase 3 Type 2 Diabetes Trialhttps://reachmd.com/news/retatrutide-a1c-weight-phase-3-type-2-diabetes-trial/2487636/Key Takeaways Retatrutide was associated with larger HbA1c reductions than placebo at all evaluated doses over 40 weeks. Body weight decreased more with retatrutide than with placebo during the same 40-week period. Gastrointestinal events were
- Oral HRS-7535 Lowers HbA1c in Metformin-Treated Type 2 Diabeteshttps://reachmd.com/news/oral-hrs-7535-lowers-hba1c-in-metformin-treated-type-2-diabetes/2487369/Key Takeaways All active HRS-7535 doses were associated with greater HbA1c reduction than placebo at week 16, with placebo-adjusted differences ranging from -0.94% to -1.57%. Higher proportions reached HbA1c below 7.0%, fasting and 2-hour postprandial
- Achieving Optimal Cardiovascular Health to Reduce Dementia Risk in Type 2 Diabeteshttps://reachmd.com/news/achieving-optimal-cardiovascular-health-to-reduce-dementia-risk-in-type-2-diabetes/2484364/A preliminary study being presented at the American Heart Association (AHA) Scientific Sessions suggests that amon
- Meat Consumption Significantly Raises Type 2 Diabetes Riskhttps://reachmd.com/news/meat-consumption-significantly-raises-type-2-diabetes-risk/2467973/Study:
- Rheumatoid Arthritis Drug Shows Promise as Type 1 Diabetes Treatmenthttps://reachmd.com/news/rheumatoid-arthritis-drug-shows-promise-as-type-1-diabetes-treatment/2457135/
- Innovations in Personalized Cancer Therapy: Insights from the I-PREDICT Trialhttps://reachmd.com/news/innovations-in-personalized-cancer-therapy-insights-from-the-i-predict-trial/2485275/The I-PREDICT trial shows tumor-DNA personalization of multi-drug regimens improves response and survival without increasing severe toxicity—a clin
- Revolutionizing Diabetic Kidney Disease Care with Predictive Biomarkershttps://reachmd.com/news/revolutionizing-diabetic-kidney-disease-care-with-predictive-biomarkers/2475945/More than one-third of individuals with type 2 diabetes will develop chronic kidney disease before symptoms emerge, demanding a paradigm shift toward predictive biomarker–guided care. Diabetes-induced chronic kidney disease advances asymptomatically, often eluding detection until glo
- Enhancing Diabetes Management with Non-Pharmacological Strategieshttps://reachmd.com/news/enhancing-diabetes-management-with-non-pharmacological-strategies/2475119/Non-pharmacological strategies such as chromium-enriched glucomannan-fructo-oligosaccharide complexes and curcumin may contribute to the management of insulin spikes and inflammation in type 2 diabetes. Clinicians increasingly recogniz
- Century-Old Vaccine Found to Protect Type 1 Diabetics from Infectious Diseaseshttps://reachmd.com/news/century-old-vaccine-found-to-protect-type-1-diabetics-from-infectious-diseases/2463149/Graphical abstract. Credit: iScience (2024). DOI: 10.1016/j.isci.2024.109881 In new research, investigators at Massac